These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16413713)

  • 41. Immunostimulatory biodegradable implants containing the adjuvant Quil-A--Part I: Physicochemical characterisation.
    Myschik J; Eberhardt F; Rades T; Hook S
    J Drug Target; 2008 Apr; 16(3):213-23. PubMed ID: 18365883
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
    Kranz H; Bodmeier R
    Eur J Pharm Sci; 2008 Jul; 34(2-3):164-72. PubMed ID: 18501569
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure of immune stimulating complex matrices and immune stimulating complexes in suspension determined by small-angle x-ray scattering.
    Pedersen JS; Oliveira CL; Hübschmann HB; Arleth L; Manniche S; Kirkby N; Nielsen HM
    Biophys J; 2012 May; 102(10):2372-80. PubMed ID: 22677391
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preparation of cefpodoxime proxetil fine particles using supercritical fluids.
    Chu J; Li G; Row KH; Kim H; Lee YW
    Int J Pharm; 2009 Mar; 369(1-2):85-91. PubMed ID: 19041383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo activity of cationic immune stimulating complexes (PLUSCOMs).
    McBurney WT; Lendemans DG; Myschik J; Hennessy T; Rades T; Hook S
    Vaccine; 2008 Aug; 26(35):4549-56. PubMed ID: 18585421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
    Liu J; Gong T; Wang C; Zhong Z; Zhang Z
    Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Saponin-adjuvanted particulate vaccines for clinical use.
    Skene CD; Sutton P
    Methods; 2006 Sep; 40(1):53-9. PubMed ID: 16997713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ni2+-mediated mitoxantrone encapsulation: improved efficacy of fast release formulation.
    Cui J; Li C; Wang L; Wang C; Yang H; Li Y; Zhang L; Zhang L; Guo W; Liang M
    Int J Pharm; 2009 Feb; 368(1-2):24-30. PubMed ID: 18973800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assess the nature of cholesterol-lipid interactions through the chemical potential of cholesterol in phosphatidylcholine bilayers.
    Ali MR; Cheng KH; Huang J
    Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5372-7. PubMed ID: 17372226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.
    Morein B; Sundquist B; Höglund S; Dalsgaard K; Osterhaus A
    Nature; 1984 Mar 29-Apr 4; 308(5958):457-60. PubMed ID: 6709052
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incorporation of the major outer membrane protein of Neisseria gonorrhoeae in saponin-lipid complexes (iscoms): chemical analysis, some structural features, and comparison of their immunogenicity with three other antigen delivery systems.
    Kersten GF; Teerlink T; Derks HJ; Verkleij AJ; van Wezel TL; Crommelin DJ; Beuvery EC
    Infect Immun; 1988 Feb; 56(2):432-8. PubMed ID: 3123391
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains.
    Alipour M; Halwani M; Omri A; Suntres ZE
    Int J Pharm; 2008 May; 355(1-2):293-8. PubMed ID: 18164881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Soluble proteins incorporate into ISCOMs after covalent attachment of fatty acid.
    Reid G
    Vaccine; 1992; 10(9):597-602. PubMed ID: 1323901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Betamethasone-in-cyclodextrin-in-liposome: the effect of cyclodextrins on encapsulation efficiency and release kinetics.
    Piel G; Piette M; Barillaro V; Castagne D; Evrard B; Delattre L
    Int J Pharm; 2006 Apr; 312(1-2):75-82. PubMed ID: 16455215
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
    Padamwar MN; Pokharkar VB
    Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cholesterol reverts Triton X-100 preferential solubilization of sphingomyelin over phosphatidylcholine: a 31P-NMR study.
    Ahyayauch H; Collado MI; Goñi FM; Lichtenberg D
    FEBS Lett; 2009 Sep; 583(17):2859-64. PubMed ID: 19647740
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phosphatidylcholine vesicle-mediated decomposition of hydrogen peroxide.
    Yoshimoto M; Miyazaki Y; Umemoto A; Walde P; Kuboi R; Nakao K
    Langmuir; 2007 Aug; 23(18):9416-22. PubMed ID: 17655340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of protective and mucosal immunity against diphtheria by a immune stimulating complex (ISCOMS) based vaccine.
    Aguila A; Donachie AM; Peyre M; McSharry CP; Sesardic D; Mowat AM
    Vaccine; 2006 Jun; 24(24):5201-10. PubMed ID: 16650917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ISCOM technology-based Matrix M™ adjuvant: success in future vaccines relies on formulation.
    Lövgren Bengtsson K; Morein B; Osterhaus AD
    Expert Rev Vaccines; 2011 Apr; 10(4):401-3. PubMed ID: 21506635
    [No Abstract]   [Full Text] [Related]  

  • 60. Confocal Raman microscopy to probe content uniformity of a lipid based powder for inhalation: a quality by design approach.
    Schoenherr C; Haefele T; Paulus K; Francese G
    Eur J Pharm Sci; 2009 Aug; 38(1):47-54. PubMed ID: 19501161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.